Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

JCR Pharmaceuticals to initiate development of JR-171 for Hurler Syndrome

Oct. 30, 2017

Japan Tobacco and Torii sign Japanese development and commercialization agreement for JTZ-951

Oct. 27, 2017

Saniona will perform interim analysis of Tesomet study in Prader-Willi syndrome

Oct. 27, 2017

Novel Fc fusion GDF15 molecules for the treatment of obesity

Oct. 26, 2017

FDA orphan drug status granted to Synlogic's SYNB-1618

Oct. 25, 2017

GPR119 agonists presented by Mankind Pharma

Oct. 24, 2017

Wilson Therapeutics to initiate pivotal phase III FOCuS study of WTX-101 in Wilson disease

Oct. 24, 2017

Novel GLP-1-dexamethasone conjugates reverse immune-metabolic dysfunction and obesity

Oct. 24, 2017

FDA approves Bydureon BCise

Oct. 23, 2017

Protalix Biotherapeutics licenses PRX-102 to Chiesi outside U.S.

Oct. 19, 2017

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...